Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hana Alabdulkarim"'
Autor:
Hussain A. Al-Omar, Ali Alshehri, Saleh A. Alqahtani, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S. Eldin
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 11, Pp 102192- (2024)
Introduction: Saudi Arabia has experienced an increasing trend in obesity prevalence in the last three decades; obesity is a significant risk factor for non-communicable diseases, which may cause healthcare and economic burdens. In this systematic re
Externí odkaz:
https://doaj.org/article/82223d811dd84d4f8f5c199e87543057
Autor:
Nora Alkhudair, Majed Alshamrani, Hadeel Samarkandi, Hajer Almodaheem, Hana Alabdulkarim, Mai Alsaqaaby, Fouad Alnajjar, Hashem Alhashem, Mohammed Bakkar, Shouki Bazarbashi, Mohammed Alnahedh, Feras Alfraih, Mohammad Alawagi, Ahmed Al-jedai
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 2, Pp 115-120 (2021)
Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the i
Externí odkaz:
https://doaj.org/article/abcd3f7b889a4b59afe9b1084389dcfb
Autor:
Jesse D. Malkin, Drishti Baid, Reem F. Alsukait, Taghred Alghaith, Mohammed Alluhidan, Hana Alabdulkarim, Abdulaziz Altowaijri, Ziyad S. Almalki, Christopher H. Herbst, Eric Andrew Finkelstein, Sameh El-Saharty, Nahar Alazemi
Publikováno v:
PLoS ONE, Vol 17, Iss 3 (2022)
Context The prevalence of overweight and obesity in Saudi Arabia has been rising. Although the health burden of excess weight is well established, little is known about the economic burden. Aims To assess the economic burden—both direct medical cos
Externí odkaz:
https://doaj.org/article/24079ec6aad84c449beaddc6d3ed99bb
Autor:
Hussain A. Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S. Eldin, Saleh A. Alqahtani
Publikováno v:
Advances in Therapy. 40:1430-1443
Autor:
Ahmed Hamdan Al-Jedai, James Lomas, Hajer Yousef Almudaiheem, Yazed Sulaiman H. Al-Ruthia, Shabab Alghamdi, Nancy Awad, Ahlam Alghamdi, Mohammad A. Alowairdhi, Hana Alabdulkarim, Majid Almadi, Reem F. Bunyan, Jessica Ochalek
Publikováno v:
Journal of Medical Economics. 26:128-138
Saudi Arabia's Vision 2030 aims to reform health care across the Kingdom, with health technology assessment being adopted as one tool promising to improve the efficiency with which resources are used. An understanding of the opportunity costs of reim
Autor:
Saleh A. Alqahtani, Hussain A. Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S. Eldin, Volker Schnecke
Publikováno v:
Advances in Therapy. 40:1114-1128
Methodological and bibliometric examination of systematic reviews of digital biomarker-based studies
Publikováno v:
2022 IEEE 20th Jubilee International Symposium on Intelligent Systems and Informatics (SISY).
Autor:
Jesse D. Malkin, Drishti Baid, Reem F. Alsukait, Taghred Alghaith, Mohammed Alluhidan, Hana Alabdulkarim, Abdulaziz Altowaijri, Ziyad S. Almalki, Christopher H. Herbst, Eric Andrew Finkelstein, Sameh El-Saharty, Nahar Alazemi
Publikováno v:
PloS one. 17(3)
Context The prevalence of overweight and obesity in Saudi Arabia has been rising. Although the health burden of excess weight is well established, little is known about the economic burden. Aims To assess the economic burden—both direct medical cos
Autor:
Mohammad Alawagi, Ahmed Al-Jedai, Hajer Almodaheem, Fouad AlNajjar, Hana Alabdulkarim, Majed Alshamrani, Mohammed Alnahedh, Mai AlSaqa’aby, Hashem Alhashem, Hadeel Samarkandi, Feras Alfraih, Nora Alkhudair, Shouki Bazarbashi, Mohammed Bakkar
Publikováno v:
Saudi Pharmaceutical Journal, Vol 29, Iss 2, Pp 115-120 (2021)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the i
Publikováno v:
Global Journal of Medical Therapeutics. 1
Background: Pharmacoeconomics (PE) is a useful tool that aid decision makers in evaluating the affordability of and access to rational drug use. Despite the potential value of PE there are several challenges with the application of this concept. In